Holen Sie sich die Stockscreener-App
6.67
5.12%
-0.36
Schlusskurs vom Vortag:
$7.03
Offen:
$7.07
24-Stunden-Volumen:
2.96M
Relative Volume:
2.11
Marktkapitalisierung:
$1.11B
Einnahmen:
$53.61M
Nettoeinkommen (Verlust:
$-142.52M
KGV:
-6.009
EPS:
-1.11
Netto-Cashflow:
$-141.83M
1W Leistung:
+1.52%
1M Leistung:
+12.29%
6M Leistung:
-48.29%
1J Leistung:
+33.67%
1-Tages-Spanne:
$6.61
$7.07
1-Wochen-Bereich:
$6.4211
$7.18
52-Wochen-Spanne:
$4.75
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Vergleichen Sie WVE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
6.67 | 1.11B | 53.61M | -142.52M | -141.83M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Eingeleitet | Wedbush | Outperform |
| 2025-02-25 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
| 2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Eingeleitet | Raymond James | Outperform |
| 2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
| 2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Eingeleitet | Guggenheim | Buy |
| 2019-07-15 | Eingeleitet | Cowen | Market Perform |
| 2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-08-07 | Eingeleitet | Stifel | Buy |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-07 | Eingeleitet | Jefferies | Buy |
| 2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Wave Life Sciences’s SWOT analysis: RNA editing pioneer faces fierce competition - Investing.com Canada
Insider Sell: Gregory Verdine Sells 30,000 Shares of WAVE Life S - GuruFocus
Insider Sell: Gregory Verdine Sells 30,000 Shares of WAVE Life Sciences Ltd (WVE) - GuruFocus
Wave Life Sciences (NASDAQ:WVE) Coverage Initiated at Raymond James - Defense World
WVE Stock Update: Raymond James Rates WAVE Life Sciences 'Outper - GuruFocus
Wave Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of “Buy” from Analysts - Defense World
Elkedonia closes EUR 11 million seed round to advance neuroplastogens as novel therapeutics for depression and neuropsychiatric disorders - GlobeNewswire Inc.
Equities Analysts Offer Predictions for WVE FY2026 Earnings - Defense World
Raymond James Initiates Coverage on Wave Life Sciences (WVE) with Bullish Outlook | WVE Stock News - GuruFocus
California State Teachers Retirement System Purchases 23,215 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Squarepoint Ops LLC Acquires New Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.04 Million Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
10,414 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Acquired by Ameriprise Financial Inc. - Defense World
(WVE) Proactive Strategies - news.stocktradersdaily.com
Wave Life Sciences at Jefferies Conference: RNA Innovation Unveiled By Investing.com - Investing.com South Africa
Wave Life Sciences at Jefferies Conference: RNA Innovation Unveiled - Investing.com Australia
Risks Still Elevated At These Prices As Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Dive 26% - simplywall.st
Nuveen Asset Management LLC Has $6.85 Million Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference | WVE Stock News - GuruFocus
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference - GlobeNewswire
Wave Life Sciences CEO Reveals Next-Gen RNA Medicine Plans at Major Healthcare Conference - Stock Titan
Wave Life Sciences Announces Appointment Of Dr. Christopher Wright As Chief Medical Officer - marketscreener.com
Wave Life Sciences (WVE) Appoints New Chief Medical Officer | WV - GuruFocus
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer - GlobeNewswire
Wave Life Sciences (WVE) Appoints New Chief Medical Officer | WVE Stock News - GuruFocus
Harvard Professor to Chief Medical Officer: Wave Life Sciences Taps RNA Expert Behind Breakthrough FDA Approvals - Stock Titan
WaVe Life Sciences’ SWOT analysis: RNA editing pioneer faces fierce competition - Investing.com Nigeria
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $648,000 Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Bank of America Corp DE Acquires 160,820 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Deutsche Bank AG Purchases 25,756 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Is Wave Life Sciences (WVE) the Best Low Priced Biotech Stock to Buy Now? - MSN
Preclinical data for Wave’s INHIBE GalNAc-siRNA in obesity - BioWorld MedTech
BNP Paribas Financial Markets Increases Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wave Life Sciences Ltd. (NASDAQ:WVE) Given Average Rating of “Buy” by Analysts - Defense World
Wave Life Sciences Ltd. (NASDAQ:WVE) Holdings Increased by Northern Trust Corp - Defense World
(WVE) On The My Stocks Page - news.stocktradersdaily.com
FY2025 Earnings Estimate for WVE Issued By Cantor Fitzgerald - Defense World
Raymond James Financial Inc. Takes $157,000 Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
H.C. Wainwright maintains $22 target on WAVE Life Sciences stock - Investing.com Australia
H.C. Wainwright maintains $22 target on WAVE Life Sciences stock By Investing.com - Investing.com India
Wave Life Sciences (NASDAQ:WVE) Stock Rating Lowered by StockNews.com - Defense World
Wave Life Sciences First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Despite shrinking by US$215m in the past week, Wave Life Sciences (NASDAQ:WVE) shareholders are still up 407% over 3 years - simplywall.st
RBC Cuts Price Target on Wave Life Sciences to $9 From $10, Keeps Sector Perform, Speculative Risk - marketscreener.com
Wave Life Sciences Reports Q1 2025 Financials and Progress - TipRanks
Wave Life Sciences: Q1 Earnings Snapshot - New Haven Register
WAVE Life Sciences Ltd (WVE) Q1 2025 Earnings Call Highlights: Clinical Advancements and ... - Yahoo Finance
Wave Life Sciences (NASDAQ:WVE) Shares Gap Down Following Weak Earnings - Defense World
Decoding WAVE Life Sciences Ltd (WVE): A Strategic SWOT Insight - GuruFocus
Transcript : Wave Life Sciences Ltd., Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):